| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | TBLA | United States | $3.42 | $1,912,040,000.00 | Strong Buy | 4 | 2021 |
#2 | BCRX | United States | $8.32 | $25,186,000.00 | Strong Buy | 11 | 1995 |
#3 | VRRM | United States | $2.95 | $132,969,000.00 | Buy | 5 | 2016 |
#4 | SRTA | United States | $5.11 | $197,141,000.00 | Strong Buy | 4 | 2019 |
#5 | ORN | United States | $8.32 | $852,260,000.00 | Strong Buy | 4 | 2007 |
#6 | HLLY | United States | $2.42 | $613,514,000.00 | Strong Buy | 6 | 2020 |
#7 | LFMD | United States | $2.86 | $12,468,578.00 | Strong Buy | 7 | 2012 |
#8 | GDRX | United States | $3.25 | $796,853,000.00 | Buy | 9 | 2020 |
#9 | RUN | United States | $7.59 | $858,578,000.00 | Buy | 20 | 2015 |
#10 | PUMP | United States | $9.10 | $1,269,158,000.00 | Buy | 7 | 2017 |
#11 | THRY | United States | $1.58 | $785,015,000.00 | Buy | 4 | 2020 |
#12 | ALHC | United States | $7.89 | $3,948,719,000.00 | Buy | 8 | 2021 |
#13 | BBOT | United States | $3.95 | $0.00 | Strong Buy | 7 | 2024 |
#14 | PALI | United States | $1.45 | $260,000.00 | Strong Buy | 7 | 2019 |
#15 | IPSC | United States | $1.65 | $109,164,000.00 | Strong Buy | 4 | 2021 |
#16 | SABS | United States | $3.27 | $0.00 | Strong Buy | 4 | 2020 |
#17 | KLRS | United States | $2.87 | $165,000.00 | Strong Buy | 4 | 2020 |
#18 | EVMN | United States | $8.39 | $13,000,000.00 | Strong Buy | 10 | 2025 |
#19 | NUVB | United States | $5.59 | $62,902,000.00 | Strong Buy | 8 | 2020 |
#20 | NRXP | United States | $2.90 | $1,225,000.00 | Strong Buy | 4 | 2017 |
#21 | BMEA | United States | $1.25 | $0.00 | Strong Buy | 6 | 2021 |
#22 | ACRS | United States | $5.17 | $1,683,000.00 | Strong Buy | 5 | 2015 |
#23 | COMP | United States | $8.97 | $6,961,600,000.00 | Strong Buy | 10 | 2021 |
#24 | BIOA | United States | $7.11 | $8,995,000.00 | Strong Buy | 6 | 2024 |
#25 | ARVN | United States | $7.39 | $262,600,000.00 | Buy | 19 | 2018 |
#26 | MFA | United States | $7.98 | $0.00 | Buy | 6 | 1998 |
#27 | BLND | United States | $1.05 | $123,585,000.00 | Buy | 6 | 2021 |
#28 | AGNC | United States | $9.41 | $0.00 | Buy | 13 | 2008 |
#29 | IKT | United States | $2.02 | $0.00 | Strong Buy | 5 | 2020 |
#30 | SOC | United States | $3.51 | $0.00 | Buy | 4 | 2021 |
#31 | KRMD | United States | $3.02 | $41,127,366.00 | Strong Buy | 4 | 2019 |
#32 | RLMD | United States | $3.75 | $13,070.00 | Strong Buy | 5 | 2012 |
#33 | FEMY | United States | $2.09 | $2,293,313.00 | Strong Buy | 4 | 2021 |
#34 | REAL | United States | $8.76 | $692,845,000.00 | Buy | 8 | 2019 |
#35 | PHAT | United States | $7.31 | $175,110,000.00 | Strong Buy | 6 | 2019 |
#36 | EVLV | United States | $4.66 | $145,905,000.00 | Strong Buy | 4 | 2020 |
#37 | BEEM | United States | $1.14 | $28,236,000.00 | Strong Buy | 4 | 2018 |
#38 | LXEO | United States | $3.02 | $654,000.00 | Strong Buy | 9 | 2023 |
#39 | COUR | United States | $4.64 | $757,500,000.00 | Buy | 15 | 2021 |
#40 | TARA | United States | $3.25 | $2,948,000.00 | Strong Buy | 5 | 2014 |
#41 | IMUX | United States | $9.32 | $0.00 | Strong Buy | 6 | 2013 |
#42 | IMRX | United States | $4.08 | $0.00 | Strong Buy | 5 | 2021 |
#43 | SLDB | United States | $6.97 | $8,094,000.00 | Strong Buy | 11 | 2017 |
#44 | ALLO | United States | $1.61 | $0.00 | Strong Buy | 15 | 2018 |
#45 | OPAD | United States | $3.31 | $567,812,000.00 | Buy | 4 | 2020 |
#46 | FATE | United States | $2.32 | $6,646,000.00 | Buy | 6 | 2013 |
#47 | RCKT | United States | $2.58 | $0.00 | Buy | 14 | 2014 |
#48 | ALXO | United States | $1.34 | $0.00 | Strong Buy | 4 | 2020 |
#49 | MAX | United States | $9.26 | $1,113,600,000.00 | Buy | 5 | 2020 |
#50 | FHTX | United States | $3.48 | $30,909,000.00 | Strong Buy | 8 | 2020 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $10 to Buy (September 30, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.